- Home
- SRXH vs PULM Comparison
SRXH vs PULM Comparison
Compare SRXH & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRXH
- PULM
- Stock Information
- Founded
- SRXH 2013
- PULM 2003
- Country
- SRXH Canada
- PULM United States
- Employees
- SRXH N/A
- PULM 2
- Industry
- SRXH
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- SRXH
- PULM Health Care
- Exchange
- SRXH NYSE
- PULM Nasdaq
- Market Cap
- SRXH 27.7M
- PULM 28.3M
- IPO Year
- SRXH N/A
- PULM N/A
- Fundamental
- Price
- SRXH $0.54
- PULM $8.98
- Analyst Decision
- SRXH
- PULM
- Analyst Count
- SRXH 0
- PULM 0
- Target Price
- SRXH N/A
- PULM N/A
- AVG Volume (30 Days)
- SRXH 7.1M
- PULM 20.6K
- Earning Date
- SRXH 05-15-2025
- PULM 05-15-2025
- Dividend Yield
- SRXH N/A
- PULM N/A
- EPS Growth
- SRXH N/A
- PULM N/A
- EPS
- SRXH N/A
- PULM N/A
- Revenue
- SRXH $119,421,918.00
- PULM $1,921,000.00
- Revenue This Year
- SRXH $26.28
- PULM N/A
- Revenue Next Year
- SRXH $25.00
- PULM $134.88
- P/E Ratio
- SRXH N/A
- PULM N/A
- Revenue Growth
- SRXH 26.27
- PULM N/A
- 52 Week Low
- SRXH $0.47
- PULM $1.78
- 52 Week High
- SRXH $6.80
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- SRXH N/A
- PULM 69.60
- Support Level
- SRXH N/A
- PULM $7.94
- Resistance Level
- SRXH N/A
- PULM $9.37
- Average True Range (ATR)
- SRXH 0.00
- PULM 0.67
- MACD
- SRXH 0.00
- PULM 0.29
- Stochastic Oscillator
- SRXH 0.00
- PULM 88.51
About SRXH SRX HEALTH SOLUTIONS INC
SRX HealthSolutions Inc is an integrated, Canadian healthcare service provider operating within the specialty healthcare industry. It has developed a collaborative specialty healthcare network (the SRx Network) that strategically positions SRx to achieve business objectives. The SRx Network is comprised of 29 specialty pharmacies, 40 infusion clinics and injection sites, four clinical trials sites, patient support programs (PSP), an allied health team and nursing services, and a wholly owned Health Canada-accredited pharmaceutical wholesale and distribution facility located in Mississauga, Ontario. The SRx Network extends across all 10 Canadian provinces, making it one of the accessible providers of comprehensive, integrated and customized specialty healthcare services in Canada.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).